| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42,0 k € | +71.8% | 24,5 k € | +16.5% | 21,0 k € | +69.8% | 12,4 k € | -75.0% | 49,4 k € | +20.2% | 41,1 k € | +6.6% | 38,6 k € | -47.6% | 73,6 k € | +73.7% | 42,4 k € | +10.4% | 38,4 k € | -61.8% | 100,4 k € | +136.3% | 42,5 k € | -85.8% | 299,6 k € | +66.0% | 180,5 k € | +14.7% | 157,3 k € | +89.3% | 83,1 k € | +44.8% | 57,4 k € | |
| Gross margin | 22,9 k € | +437.7% | 4,3 k € | -56.4% | 9,8 k € | +838.5% | -1,3 k € | -103.9% | 33,7 k € | +33.9% | 25,2 k € | +21.9% | 20,7 k € | -64.5% | 58,2 k € | +113.3% | 27,3 k € | +34.5% | 20,3 k € | -72.9% | 74,8 k € | +236.2% | 22,3 k € | -91.8% | 272,9 k € | +75.9% | 155,2 k € | +16.5% | 133,2 k € | +161.8% | 50,9 k € | +34.7% | 37,8 k € | |
| EBITDA | 22,8 k € | +435.2% | 4,3 k € | -52.5% | 9,0 k € | +744.9% | -1,4 k € | -104.1% | 33,7 k € | +36.0% | 24,8 k € | +20.0% | 20,7 k € | -64.5% | 58,2 k € | +113.3% | 27,3 k € | +34.5% | 20,3 k € | -72.9% | 74,8 k € | +236.2% | 22,3 k € | -91.8% | 272,8 k € | +76.0% | 155,0 k € | +16.4% | 133,2 k € | +161.8% | 50,9 k € | +34.7% | 37,8 k € | |
| Operating profit | 17,1 k € | +1149.3% | -1,6 k € | -126.3% | 6,2 k € | +184.3% | -7,3 k € | -126.2% | 28,0 k € | +45.2% | 19,3 k € | +27.4% | 15,1 k € | -71.3% | 52,6 k € | +135.7% | 22,3 k € | +49.3% | 15,0 k € | -78.5% | 69,5 k € | +333.9% | 16,0 k € | -94.0% | 266,8 k € | +79.4% | 148,7 k € | +17.4% | 126,6 k € | +186.1% | 44,3 k € | +22.4% | 36,2 k € | |
| Profit/loss | 10,4 k € | +564.6% | -2,2 k € | -157.2% | 3,9 k € | +152.0% | -7,5 k € | -138.1% | 19,8 k € | +36.3% | 14,5 k € | +54.0% | 9,4 k € | -73.1% | 35,0 k € | +123.6% | 15,6 k € | +12.7% | 13,9 k € | -68.0% | 43,4 k € | +545.3% | 6,7 k € | -96.8% | 210,6 k € | +114.5% | 98,2 k € | +19.5% | 82,1 k € | +199.5% | 27,4 k € | +19.2% | 23,0 k € | |
| Equity | 610,3 k € | +1.7% | 599,9 k € | -0.4% | 602,1 k € | +0.7% | 598,2 k € | -1.2% | 605,7 k € | +3.4% | 586,0 k € | +2.5% | 571,5 k € | +1.7% | 562,1 k € | +6.6% | 527,1 k € | +3.1% | 511,5 k € | +2.8% | 497,6 k € | +9.6% | 454,2 k € | +1.5% | 447,5 k € | +88.9% | 237,0 k € | +70.7% | 138,8 k € | +145.0% | 56,6 k € | +93.9% | 29,2 k € | |
| Total assets | 612,3 k € | +2.1% | 599,9 k € | -0.4% | 602,1 k € | +0.1% | 601,7 k € | -1.0% | 608,0 k € | +3.6% | 587,1 k € | +0.8% | 582,5 k € | +0.4% | 580,3 k € | +5.9% | 548,2 k € | +1.8% | 538,6 k € | +0.1% | 538,3 k € | +5.9% | 508,3 k € | -3.2% | 525,3 k € | +105.1% | 256,1 k € | +52.1% | 168,4 k € | +90.6% | 88,4 k € | +144.9% | 36,1 k € | |
| Cash | 44,0 k € | -62.3% | 116,6 k € | -2.1% | 119,1 k € | -17.8% | 144,9 k € | +1.2% | 143,2 k € | +31.6% | 108,8 k € | +7.0% | 101,7 k € | -74.7% | 402,6 k € | -2.2% | 411,6 k € | -3.3% | 425,7 k € | +7.3% | 396,7 k € | -1.6% | 403,3 k € | +11.2% | 362,6 k € | +1357.0% | 24,9 k € | — | — | — | ||||
| Debts | 2,0 k € | — | — | 3,5 k € | +54.0% | 2,3 k € | +107.3% | 1,1 k € | -90.0% | 11,0 k € | -39.5% | 18,2 k € | -13.5% | 21,1 k € | -22.1% | 27,1 k € | -33.4% | 40,7 k € | -24.8% | 54,1 k € | -30.5% | 77,8 k € | +306.0% | 19,2 k € | -35.3% | 29,6 k € | -6.6% | 31,7 k € | +362.0% | 6,9 k € | ||||
Private limited company · Jalhay · incorporated on 20/02/2009
Private limited company profitable and well capitalised. Cash position declining (-62.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SOCIETE DE RECHERCHE ET DE CONSULTANCE EN SANTE is a Private limited company incorporated in 2009. Its main activity is: Management consultancy activities. Its registered office is in Jalhay.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette